Noah Q3 Adjusted Earnings Rise, Revenue Falls-March 2024-www.financetom.com

Noah Q3 Adjusted Earnings Rise, Revenue Falls

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Noah Q3 Adjusted Earnings Rise, Revenue Falls

Nov 25, 2025 2:14 PM

04:49 PM EST, 11/25/2025 (MT Newswires) -- Noah Holdings ( NOAH ) reported Q3 adjusted earnings late Tuesday of 3.26 renminbi ($0.46) per diluted American depositary share, up from 2.14 renminbi a year earlier.

Revenue in the three months ended Sept. 30 fell to 632.9 million renminbi from 683.7 million renminbi a year earlier.

Previous page： Ingredion Stops Operations at Manufacturing Facility in Vanscoy, Canada Next page： OSI Systems Secures $27 Million Order for Screening Solutions

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Ingredion Stops Operations at Manufacturing Facility in Vanscoy, Canada

Jan 6, 2025

11:19 AM EST, 01/06/2025 (MT Newswires) -- Ingredion ( INGR ) said Monday it has stopped operations at its plant protein manufacturing facility in Vanscoy, Canada, affecting about 20 employees. The company said it intends to sell the facility and the property, though it has yet to enter into a sale agreement. Ingredion ( INGR ) expects to book about...

OSI Systems Secures $27 Million Order for Screening Solutions

Jan 6, 2025

11:23 AM EST, 01/06/2025 (MT Newswires) -- OSI Systems ( OSIS ) said Monday that its security division received an order for about $27 million from an international customer for checkpoint and hold baggage screening products. The order includes Real Time Tomography 110 explosive detection system, Orion 920 Computed Tomography checkpoint screening system integrated with Rapiscan tray return system, Orion...

Why CureVac (CVAC) Stock Is Rising

Jan 6, 2025

Shares of CureVac BV are trading higher by 13.5% to $4.10 during Monday’s session following a CDC report highlighting a significant increase in acute respiratory illnesses nationwide. The surge in healthcare visits, driven by higher cases of seasonal influenza, COVID-19 and RSV, has renewed interest in vaccine and therapeutic manufacturers during Monday’s trading session. CureVac ( CVAC ), a biotechnology...

Why AEON Biopharma Stock Is Down 65% Today

Jan 6, 2025

AEON Biopharma Inc ( AEON ) shares are trading lower by 65% to 19 cents during Monday’s session after the company announced the pricing of a $20 million offering of 40 million units at 50 cents per unit. The funds will support AEON's development of ABP-450, a biosimilar to BOTOX for therapeutic use and enable comparative studies under the 351(k) pathway. CEO Marc Forth...